For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease ...

City Council approved a special use permit Tuesday allowing the construction of a 170-foot communications tower on South ...

A study led by Maria Carmo-Fonseca at GIMM has helped clarify one of the main limitations of lab-grown heart cells, which are ...

Biology has always been an unruly science. Cells divide when they want to. Genes switch on and off like temperamental lights.

The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...

In our latest interview, News-Medical speaks with Rosanna Zhang from ACROBiosystems about utilizing organoids for disease ...

A study led by Maria Carmo-Fonseca at the GIMM Foundation has helped clarify one of the main limitations of lab-grown heart ...

UCSF researchers have discovered a way to identify deadly lung infections with improved accuracy by pairing AI with a unique ...

During a live event, Matthew Lunning, DO, interpreted long-term outcomes of the ZUMA-7 and TRANSFORM trials.

Alzheimer’s disease affects millions worldwide—but confirming a diagnosis is far from simple. Doctors currently rely on ...

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a new Cambridge-led trial has found.

In a season marked by early surges and a dominant drifted strain, experts stress layered protection. For the millions vaccinated and not vaccinated this year, innovations like Polyrizon's PL-16 has ...